Breast Cancer: New Test Predicts Recurrence

The new test is called ONCOTYRE DX and was developed by Genomic Health Inc. It is based on oncogene expression, and assists oncologist in deciding which patients should undergo chemotherapy.

Reference: Oncology Times 2/25/04

Webmaster

May 17, 2004